Seeing Is Believing
Healthcare - Sector
EBS is currently covered by 1 analysts with an average price target of $12. This is a potential upside of $4.64 (47.42%) from yesterday's end of day stock price of $8.14.
Emergent Biosolutions's activity chart (see below) currently has 20 price targets and 33 ratings on display. The stock rating distribution of EBS is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 67.83% with an average time for these price targets to be met of 152.43 days.
Highest price target for EBS is $12, Lowest price target is $12, average price target is $12.
Most recent stock forecast was given by from HC WAINWRIGHT on 09-Mar-2026. First documented stock forecast 27-Sep-2017.
Currently out of the existing stock ratings of EBS, 6 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Dec-2024
$12
$3.47 (40.68%)
$15
4 months ago
(09-Mar-2026)
0/12 (0%)
$3.65 (43.71%)
Buy Since 11-Apr-2024
$12
$3.47 (40.68%)
$8
1 years 8 months 2 days ago
(07-Nov-2024)
7/11 (63.64%)
$1 (9.09%)
72
Sell Since 20-Nov-2023
$9
2 years 7 months 19 days ago
(20-Nov-2023)
2/2 (100%)
$0.88 (10.84%)
7
Hold Since 12-Sep-2022
$15
$7.04 (88.44%)
$29
3 years 1 months 20 days ago
(19-May-2023)
4/8 (50%)
$6.83 (83.60%)
86
Buy Since 30-Apr-2021
$55
$47.04 (590.95%)
$65
3 years 8 months ago
(09-Nov-2022)
5/11 (45.45%)
$42.15 (328.02%)
140
What is EBS (Emergent Biosolutions) average time for price targets to be met?
Which analyst has the current highest performing score on EBS (Emergent Biosolutions) with a proven track record?
Which analyst has the most public recommendations on EBS (Emergent Biosolutions)?
Which analyst is the currently most bullish on EBS (Emergent Biosolutions)?
Which analyst is the currently most reserved on EBS (Emergent Biosolutions)?